Tao Articles
Peregrine and Dios in TAO production accord
11 June 2007
Warnings To Be Added To US Propulsid Labeling
1 July 1998
SBI Appoints Asian Agent
15 June 1998
Vietnam's Vinapharm Seeking Investments To Modernize
23 December 1996
Labelling Change For Cisapride
20 March 1995
FUSION VACCINE AGAINST CANCER
3 May 1993
Showing 1-7 of 7 articles
- 1
- Novo Nordisk's diabetes drug Victoza produced 8% weight loss in Ph III obesity trial
- Proposal to list Roche's Neulastim and Actemra in New Zealand
- Alchemia and Merck Serono collaborate on HA-Irinotecan with Erbitux
- Positive new data on Novartis' Galvus in elderly type 2 diabetes patients
- Johnson & Johnson expects 10 NDA filings by 2017, saying pharma sector poised for growth
